Onconetix, Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
Onconetix, Inc. (ONCO) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $7.36 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-08-13
- Onconetix, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-06-30 was $7.36K, a 76.25% decline year-over-year.
- Onconetix, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $22.30K, a 23.76% decline year-over-year.
- Onconetix, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-09-30 was $9.79K, a 78.54% decline year-over-year.
- Onconetix, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-06-30 was $30.98K.
- Onconetix, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $74.27K, a 83.07% decline from fiscal 2024.
- Onconetix, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $438.65K, a 33.02% increase from fiscal 2023.
- Onconetix, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $329.76K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.36K 10-Q · filed 2026-08-13 | $29.66K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $22.30K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $74.27K 10-K · filed 2026-03-13 | |||
| 2025-09-30 | $9.79K 10-Q · filed 2025-11-13 | $40.78K derived: sum of 2 quarters · filed 2026-08-13 | $70.03K derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-06-30 | $30.98K 10-Q · filed 2026-08-13 | $60.24K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $29.26K 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | $438.65K 10-K · filed 2026-03-13 | |||
| 2024-09-30 | $45.63K 10-Q · filed 2025-11-13 | $44.86K derived: sum of 2 quarters · filed 2025-11-13 | $97.51K derived: sum of 3 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$775.00 10-Q · filed 2025-11-13 | $51.88K derived: sum of 2 quarters · filed 2025-11-13 | ||
| 2024-03-31 | $52.65K 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | $329.76K 10-K · filed 2025-06-02 | |||
| 2023-09-30 | $105.40K 10-Q · filed 2024-12-10 | $378.18K derived: sum of 2 quarters · filed 2024-12-10 | $563.76K derived: sum of 3 quarters · filed 2024-12-10 | |
| 2023-06-30 | $272.78K 10-Q · filed 2024-12-10 | $458.36K derived: sum of 2 quarters · filed 2024-12-10 | ||
| 2023-03-31 | $185.58K 10-Q · filed 2024-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |